NOT-AG-22-051: Notice to Extend the Expiration Date of PAR-20-156 "Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional)"

Notice to Extend the Expiration Date of PAR-20-156 "Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease (R01 Clinical Trial Optional)"

Notice Number:

NOT-AG-22-051

Key Dates

Release Date:

January 10, 2023

Related Announcements

PAR-20-156 - Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease (R01 Clinical Trial Optional)

Issued by

National Institute on Aging (NIA)

Purpose

This Notice informs potential applicants that the expiration date for Funding Opportunity Announcement (FOA) PAR-20-156 "Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease (R01 Clinical Trial Optional)" will be extended by one receipt cycle. The FOA now expires on September 8, 2023.

The following section under Part 1. Overview Information of PAR-20-156 has been modified:

Key Dates

Currently Reads: Expiration Date: May 08, 2023

Revised to Read: Expiration Date: September 8, 2023

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Nandini Arunkumar, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-827-3342
Email: [email protected]